@FierceBiotech: GSK's albiglutide flunks head-to-head diabetes PhIII with rival Victoza. Article | Follow @FierceBiotech
@JohnCFierce: New PwC survey: Close to half of Americans didn't get care or take a drug due to out-of-pocket cost in last year. Release | Follow @JohnCFierce
@RyanMFierce: Roche has tapped biotech Aileron for stapled peptide tech in inflammatory diseases, no financial details though. Release | Follow @RyanMFierce
@MarkHFierce: Walgreens pharmacists and hospitals are teaching patients how to understand their new drugs before going home. Story | Follow @MarkHFierce
> Fujifilm has inked another big biosimilar deal, this time with Japan's Kyowa Hakko Kirin. The two companies plan to launch the joint venture next spring. Fujifilm, one of a number of multinational conglomerates looking to jump into biosimilar development, earlier signed a development deal with India's Dr. Reddy's. Story
> Australia's Starpharma has raised $32 million. Much of that money will be used for the development of an experimental gel that guards against HIV and genital herpes. Story
> Aileron and Roche have expanded their $1.1 billion collaboration, adding a program for inflammatory diseases. Story
> Genzyme has put up a new abstract demonstrating that mipomersen was able to reduce the levels of "bad" LDL by 47% among statin-resistant patients in a small study. Abstract
@FiercePharma: FDA staffers back Pfizer's Prevnar 13 vax for adults; advisory committee meets Wednesday. News | Follow@FiercePharma
> Archives: FDA's safety messages are incomplete. Report
> Senate bill would nix 180-day generics exclusivity. Story
> Former Genentech CEO takes chairman's role at Apple. News
> Bayer chief aims for 37% pharma growth in China. Item
> Antipsychotics, ADHD meds fuel rising psych-drug use. Report
> Novartis staffers stop work at Nyon plant in jobs protest. Story
Medical Device News
> Sera lands $19.3M, appoints Critchfield as CEO. More
> Study: Corus CAD demonstrates superiority to MPI. Item
> Accuray to cut 5% of workforce. Article
> Varian gains on word of Siemens' 'selective exit' from radiation therapy. News
Drug Delivery News
> Medgenics proceeds with biopump anemia treatment. Story
> Merck licenses Bend Research's spray-dried dispersion tech. Article
> New class of drugs may kill tumors by altering structure of crucial enzyme. More
> Cerulean Pharma enrolling for Phase 2 lung cancer trial. Piece
And Finally... The use of psychiatric drugs is growing rapidly. Now one in five adult Americans take a psych therapy. Story